PortfoliosLab logoPortfoliosLab logo
IBM vs. TGTX
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

IBM vs. TGTX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in International Business Machines Corporation (IBM) and TG Therapeutics, Inc. (TGTX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, IBM achieves a -8.10% return, which is significantly lower than TGTX's 68.74% return. Over the past 10 years, IBM has underperformed TGTX with an annualized return of 10.88%, while TGTX has yielded a comparatively higher 22.01% annualized return.


IBM

1D
-1.30%
1M
22.53%
YTD
-8.10%
6M
-11.80%
1Y
-0.59%
3Y*
29.13%
5Y*
18.25%
10Y*
10.88%

TGTX

1D
1.58%
1M
27.34%
YTD
68.74%
6M
60.14%
1Y
39.68%
3Y*
25.14%
5Y*
6.51%
10Y*
22.01%
*Multi-year figures are annualized to reflect compound growth (CAGR)

IBM vs. TGTX - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
IBM
International Business Machines Corporation
-8.10%38.23%39.27%21.85%10.64%16.65%-1.16%23.58%-22.56%-3.99%
TGTX
TG Therapeutics, Inc.
68.74%-0.96%76.23%44.38%-37.74%-63.48%368.65%170.73%-50.00%76.34%

Correlation

The correlation between IBM and TGTX is 0.06, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.06

Correlation (3Y)
Calculated over the trailing 3-year period

0.15

Correlation (5Y)
Calculated over the trailing 5-year period

0.19

Correlation (10Y)
Calculated over the trailing 10-year period

0.19

Correlation (All Time)
Calculated using the full available price history since May 3, 2010

0.16

The correlation between IBM and TGTX shifts across timeframes, from 0.06 (1 year) to 0.19 (10 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

IBM:

$255.84B

TGTX:

$8.05B

EPS

IBM:

$11.32

TGTX:

$2.87

PE Ratio

IBM:

23.74

TGTX:

17.51

PEG Ratio

IBM:

0.28

TGTX:

0.03

PS Ratio

IBM:

3.70

TGTX:

11.55

PB Ratio

IBM:

7.76

TGTX:

13.81

Total Revenue (TTM)

IBM:

$68.91B

TGTX:

$700.35M

Gross Profit (TTM)

IBM:

$40.64B

TGTX:

$581.54M

EBITDA (TTM)

IBM:

$15.71B

TGTX:

$156.88M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

IBM vs. TGTX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

IBM
IBM Risk / Return Rank: 4040
Overall Rank
IBM Sharpe Ratio Rank: 4141
Sharpe Ratio Rank
IBM Sortino Ratio Rank: 3838
Sortino Ratio Rank
IBM Omega Ratio Rank: 3737
Omega Ratio Rank
IBM Calmar Ratio Rank: 4242
Calmar Ratio Rank
IBM Martin Ratio Rank: 4141
Martin Ratio Rank

TGTX
TGTX Risk / Return Rank: 6666
Overall Rank
TGTX Sharpe Ratio Rank: 6969
Sharpe Ratio Rank
TGTX Sortino Ratio Rank: 6666
Sortino Ratio Rank
TGTX Omega Ratio Rank: 6666
Omega Ratio Rank
TGTX Calmar Ratio Rank: 6767
Calmar Ratio Rank
TGTX Martin Ratio Rank: 6464
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

IBM vs. TGTX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for International Business Machines Corporation (IBM) and TG Therapeutics, Inc. (TGTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


IBMTGTXDifference
Sharpe ratioReturn per unit of total volatility

-0.86

Sortino ratioReturn per unit of downside risk

-1.22

Omega ratioGain probability vs. loss probability

1.04

1.19

-0.15

Calmar ratioReturn relative to maximum drawdown

-0.02

1.22

-1.24

Martin ratioReturn relative to average drawdown

-0.04

2.21

-2.25

IBM vs. TGTX - Sharpe Ratio Comparison

The current IBM Sharpe Ratio is -0.02, which is lower than the TGTX Sharpe Ratio of 0.85. The chart below compares the historical Sharpe Ratios of IBM and TGTX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

IBM vs. TGTX - Drawdown Comparison

The maximum IBM drawdown since its inception was -69.40%, smaller than the maximum TGTX drawdown of -99.52%. Use the drawdown chart below to compare losses from any high point for IBM and TGTX.


Loading charts...

Drawdown Indicators


IBMTGTXDifference

Max Drawdown

Largest peak-to-trough decline

-69.40%

-99.52%

+30.12%

Max Drawdown (1Y)

Largest decline over 1 year

-30.96%

-32.66%

+1.70%

Max Drawdown (3Y)

Largest decline over 3 years

-30.96%

-74.79%

+43.83%

Max Drawdown (5Y)

Largest decline over 5 years

-30.96%

-90.75%

+59.79%

Max Drawdown (10Y)

Largest decline over 10 years

-40.59%

-93.19%

+52.60%

Current Drawdown

Current decline from peak

-18.38%

-78.45%

+60.07%

Average Drawdown

Average peak-to-trough decline

-20.12%

-91.42%

+71.30%

Ulcer Index

Depth and duration of drawdowns from previous peaks

14.43%

18.03%

-3.60%

Volatility

IBM vs. TGTX - Volatility Comparison

International Business Machines Corporation (IBM) has a higher volatility of 21.56% compared to TG Therapeutics, Inc. (TGTX) at 14.69%. This indicates that IBM's price experiences larger fluctuations and is considered to be riskier than TGTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


IBMTGTXDifference

Volatility (1M)

Calculated over the trailing 1-month period

21.56%

14.69%

+6.87%

Volatility (6M)

Calculated over the trailing 6-month period

34.63%

34.05%

+0.58%

Volatility (1Y)

Calculated over the trailing 1-year period

39.52%

47.11%

-7.59%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

27.18%

87.80%

-60.62%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

26.60%

86.90%

-60.30%

Dividends

IBM vs. TGTX - Dividend Comparison

IBM's dividend yield for the trailing twelve months is around 2.50%, while TGTX has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
IBM
International Business Machines Corporation
2.50%2.27%3.03%4.05%4.68%4.74%5.17%4.80%5.46%3.85%3.31%3.63%
TGTX
TG Therapeutics, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

IBM vs. TGTX - Financials Comparison

This section allows you to compare key financial metrics between International Business Machines Corporation and TG Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00B10.00B15.00B20.00B20222023202420252026
15.92B
204.92M
(IBM) Total Revenue
(TGTX) Total Revenue
Values in USD except per share items

IBM vs. TGTX - Profitability Comparison

The chart below illustrates the profitability comparison between International Business Machines Corporation and TG Therapeutics, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

50.0%60.0%70.0%80.0%90.0%100.0%20222023202420252026
56.2%
83.7%
Portfolio components
IBM - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, International Business Machines Corporation reported a gross profit of 8.95B and revenue of 15.92B. Therefore, the gross margin over that period was 56.2%.

TGTX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, TG Therapeutics, Inc. reported a gross profit of 171.41M and revenue of 204.92M. Therefore, the gross margin over that period was 83.7%.

IBM - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, International Business Machines Corporation reported an operating income of 1.22B and revenue of 15.92B, resulting in an operating margin of 7.6%.

TGTX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, TG Therapeutics, Inc. reported an operating income of 34.80M and revenue of 204.92M, resulting in an operating margin of 17.0%.

IBM - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, International Business Machines Corporation reported a net income of 1.22B and revenue of 15.92B, resulting in a net margin of 7.6%.

TGTX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, TG Therapeutics, Inc. reported a net income of 19.78M and revenue of 204.92M, resulting in a net margin of 9.7%.


Frequently Asked Questions


IBM and TGTX have a correlation of 0.06, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

IBM has higher volatility (21.56%) compared to TGTX (14.69%). In terms of maximum drawdown, IBM dropped -69.40% vs TGTX's -99.52%.

TGTX currently has the higher Sharpe Ratio (0.85 vs -0.01), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for IBM and TGTX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer